Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

268 results about "Hypotype" patented technology

Hypotype is a genus of moths of the family Noctuidae.

RPA-Cas12a one-step detection system and application thereof

The invention relates to the field of molecular diagnosis, in particular to an RPA-Cas12a one-step detection system and application thereof. The invention finds that heparin sodium has cleavage activity for inhibiting LbCas12a, and develops a one-step nucleic acid detection method compatible with RPA amplification and Cas12 detection based on the inhibition effect. The detection limit of the method reaches 0.6 (copy / microliter), and the method can be expanded to other two Cas12 subtype proteins, namely AsCas12a and AapCas12b. In the detection of monkey pox virus, influenza A virus and new coronavirus as examples, compared with quantitative PCR, the detection sensitivity and specificity of the method both reach 95% or above. The CRISPR one-step nucleic acid detection method has the advantages of high sensitivity and specificity, short detection time and the like, and the potential nucleic acid aerosol pollution risk of a traditional two-step nucleic acid detection method is removed.
Owner:UNIV OF SCI & TECH OF CHINA

Primer, probe composition and kit for detecting H9 subtype AIV and IBV and application

The invention provides a primer, a probe composition and a kit for detecting H9 subtype AIV (avian influenza virus) and IBV (infectious bursal virus) and application, and belongs to the technical field of fluorescence detection. According to the primer and probe composition capable of detecting the H9 subtype avian influenza virus and the avian infectious bronchitis virus, which is designed by the invention, SEQ ID NO.1-6 can be used for specifically detecting the H9 subtype avian influenza virus, the avian infectious bronchitis virus and various branch viruses of the H9 subtype avian influenza virus and the avian infectious bronchitis virus; cross reaction with other common viruses is avoided, the detection sensitivity is high, and the lowest detectable quantities of the two viruses are both 1 copy.
Owner:CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENT

Nanometer antibody aiming at influenza A virus H1N1 subtype NA protein and application thereof

The invention belongs to the technical field of biomedicine, and particularly relates to a nano antibody aiming at influenza A virus H1N1 subtype NA protein and application. The nano antibody comprises an amino acid sequence as shown in SEQ ID NO: 1 or consists of the amino acid sequence as shown in SEQ ID NO: 1. The nano antibody has high affinity, and experimental results show that the antibody can effectively inhibit proliferation of PR8 H1N1 virus in vivo and resist infection of lethal dose virus on mice. Meanwhile, the nano antibody is the first nano antibody which aims at the N1 subtype NA protein and has prevention and treatment effects, the market blank is filled, and the nano antibody can be applied to the fields of laboratory research, biosensor development, clinical diagnosis, infection prevention and treatment and the like. The nano antibody provided by the invention has the advantages of small molecular weight, high stability, low production cost and the like, and has wider application potential and market competitive advantages compared with the traditional IgG antibody.
Owner:SICHUAN UNIV

Anti-H9N2 subtype avian influenza virus paired monoclonal antibody and immunochromatography test paper and application thereof

The invention belongs to the technical field of biology, and particularly relates to a group of paired monoclonal antibodies for resisting H9N2 subtype avian influenza viruses and a surface enhanced Raman spectroscopy rapid detection test strip established based on the antibodies. The paired monoclonal antibody comprises a labeled antibody 1E9 and a capture antibody 3C10 which are prepared by taking hemagglutinin protein of the H9N2 subtype avian influenza virus as antigens and can be specifically combined with the H9N2 subtype avian influenza virus. According to the invention, an SERS (Surface Enhanced Raman Scattering) probe Au-coated Pt-4ATP is used as a marker and is coupled with a labeled antibody 1E9 to prepare a labeled probe, and the labeled probe is paired with a capture antibody 3C10 to establish an SERS immunochromatography test strip. The test strip has a colorimetric and Raman dual interpretation mode, can be used for qualitative and quantitative detection, has the advantages of strong specificity, high sensitivity, good repeatability and stability and the like, is simple and rapid in clinical detection operation, and provides reliable technical support for on-site rapid screening of subtype viruses.
Owner:LONGHU LAB

Kit for visually detecting H5 subtype avian influenza virus based on RPA-CRISPR / Cas12b system and application

The invention discloses a kit for visually detecting an H5 subtype avian influenza virus based on an RPA-CRISPR / Cas12b system and application of the kit, and belongs to the technical field of molecular detection. The kit comprises an RT-RPA (Reverse Transcription-Recombinase Polymerase Amplification) primer pair and sgRNA1 The RT-RPA primer pair comprises a forward primer with a nucleotide sequence as shown in SEQ ID NO.1 and a reverse primer with a nucleotide sequence as shown in SEQ ID NO.2; and the nucleotide sequence of the sgRNA1 is as shown in SEQ ID NO. 7. According to the kit, nucleic acid amplification and detection are synchronously completed through a tubular reaction system, the detection sensitivity reaches 1 copy / mu L, the coincidence rate with fluorescent RT-PCR is 100%, and no cross reaction exists on H7, H9, NDV and IBV. The kit does not need a complex instrument, is suitable for rapid screening on a basic level site, and provides an efficient solution for prevention and control of avian influenza.
Owner:CHINESE ACAD OF INSPECTION & QUARANTINE

Broad-spectrum influenza A vaccine immunogen composition and application

The invention belongs to the technical field of vaccines and biology, and particularly relates to a broad-spectrum influenza A vaccine immunogen composition and application. The invention provides a nucleic acid molecule for coding an immunogenic peptide, wherein the immunogenic peptide comprises: M2 protein extracellular region (M2e) peptide fragments which are connected in series; a hemagglutinin protein stem region extracellular domain (HA2) peptide fragment derived from an H7N9 influenza virus subtype; multimerization of the motif peptide fragment; and optionally, one or more linker peptide fragments independently located between the peptide fragments, wherein the polynucleotide molecule comprises a coding nucleic acid of each peptide fragment. The broad-spectrum influenza A vaccine can induce an organism to generate antigen-specific immune response, a high-titer antibody can be generated 14 days after last inoculation, the broad-spectrum influenza A vaccine can completely protect and resist attack of various subtype influenza A viruses, and the broad-spectrum influenza A vaccine has a wide application prospect.
Owner:FUDAN UNIVERSITY

CRISPR (clustered regularly interspaced short palindromic repeats) / Cas-based kit for isothermal rapid visual detection of H1N1 influenza virus and mycoplasma pneumoniae and detection method thereof

The invention provides a CRISPR (clustered regularly interspaced short palindromic repeats) / Cas-based kit for isothermal rapid visual detection of H1N1 influenza virus and mycoplasma pneumoniae and a detection method thereof. The kit and the detection method provided by the invention can be used for timely, sensitively and specifically detecting a nucleic acid target in a sample. The invention provides a lateral flow analysis (LFA) detection platform of a three-stage amplification system integrating recombinase polymerase amplification (RPA), CRISPR / Cas12a and catalytic hairpin assembly (CHA) circulation, the detection platform is used for sensitively and accurately detecting mycoplasma pneumoniae DNA (MP DNA) and influenza A virus subtype H1N1RNA (H1N1RNA), and compared with other researches based on an LFA-CRISPR / Cas12a system, the detection platform has the advantages that the detection efficiency is greatly improved, and the detection cost is reduced. According to the kit and the detection method provided by the invention, nucleic acids of two pathogens can be visually detected on a single LFA at the same time, and the sensitivity is high.
Owner:SHANDONG NORMAL UNIV

Recombinant HVT for co-expressing H9 subtype AIV HA gene, IBV S gene and IBDV VP2 gene and application thereof

The invention discloses a recombinant HVT for co-expressing an H9 subtype AIV HA gene, an IBV S gene and an IBDV VP2 gene and application of the recombinant HVT, and belongs to the technical field of medicine or veterinary medicine. The recombinant HVT is a recombinant HVT vaccine strain H30201 for co-expressing the H9 subtype AIV HA gene, the IBV S gene and the IBDV VP2 gene, which is obtained by inserting an expression cassette containing the H9 subtype AIV HA gene and the QX type IBV S gene between 95322-95323 nucleotides of an HVT FC126 strain and inserting an expression cassette containing the IBDV classic virulent strain VP2 gene between 112071-112088 nucleotides of an HVT genome at the same time through virus rescue. The invention also provides application of the recombinant HVT vaccine strain in preparation of vaccines for H9 subtype avian influenza, infectious bronchitis and infectious bursal disease.
Owner:INST OF URBAN AGRI CHINESE ACADEMY OF AGRI SCI +1

Construction method and application of recombinant herpesvirus turkey for co-expressing NDV F gene and H9 subtype AIV HA gene

The invention provides a construction method and application of a recombinant herpesvirus turkey for co-expressing an NDV (Newcastle Disease Virus) F gene and an H9 subtype AIV (Avian Influenza Virus) HA gene, and belongs to the field of genetic engineering vaccines. The recombinant clone technology is utilized, an expression framework containing a Newcastle disease virus gene VII type strain F gene and an H9 subtype avian influenza virus HA gene is inserted between 95322-95323 nucleotides or between 112071-112088 nucleotides of a turkey herpesvirus FC126 strain, and the recombinant clone with the F gene and HA gene expression framework inserted into a turkey herpesvirus genome is constructed and obtained. Recombinant turkey herpesvirus vaccine strains H20901 and H20902 for co-expressing the Newcastle disease virus F gene and the H9 subtype avian influenza virus HA gene are rescued and obtained by the recombinant turkey herpesvirus vaccine strain H20901 and H20902. The vaccine prepared from the recombinant turkey herpesvirus provided by the invention can provide dual protection for the Newcastle disease virus and the avian influenza virus, and has a good market application prospect.
Owner:INST OF URBAN AGRI CHINESE ACADEMY OF AGRI SCI +1

Multi-subtype influenza A virus nucleic acid detection kit and detection method

The invention discloses a multi-subtype influenza A virus nucleic acid detection kit and a detection method, and relates to the technical field of medical detection.The kit comprises a group of reverse transcription RT-RPA amplification primer pairs used for amplifying influenza A virus M gene target sequences, the reverse transcription RT-RPA amplification primer pairs are designed for specific areas of subtypes H1N1, H2N2, H3N2, H5N1 and H7N9, and the reverse transcription RT-RPA amplification primer pairs are designed for specific areas of subtypes H1N1, H2N2, H3N2, H5N1 and H7N9; the crRNA library comprises a plurality of crRNA molecules which are respectively complementary with different conserved regions in the M gene target sequence and is used for guiding Cas12a protein to carry out specific recognition; a Cas12a protein reagent; the reporter molecule can be subjected to non-specific cleavage by the Cas12a protein; the enzyme preparation, the buffer solution and the nucleotide substrate are required by RT-RPA reaction. The invention aims to realize synchronous, rapid, high-sensitivity and high-specificity detection of various subtype influenza A viruses.
Owner:THE FIRST AFFILIATED HOSPITAL OF XIAN MEDICAL UNIV

Recombinant turkey herpesvirus co-expressing avian influenza H9 gene and fowl adenovirus 4 type Fiber-2 gene and application of recombinant turkey herpesvirus

ActiveCN119639689AGood immune effectMeets candidate strain requirementsMicroorganism based processesAntiviralsTGE VACCINETurkey poult
The invention belongs to the technical field of biology, and discloses a recombinant turkey herpesvirus co-expressing an avian influenza H9 gene and an avian adenovirus 4 type Fiber-2 gene, the H9 gene containing a promoter and a terminator is inserted between an HVT053 site and an HVT054 site of the turkey herpesvirus, the Fiber-2 gene containing a promoter and a terminator is inserted between an HVT087 site and an HVT088 site of the turkey herpesvirus, and the recombinant turkey herpesvirus co-expressing the avian influenza H9 gene and the avian adenovirus 4 type Fiber-2 gene is obtained. The recombinant virus is obtained. The recombinant turkey herpesvirus can stably co-express the H9N2 subtype avian influenza virus H9 protein and the fowl adenovirus 4 type Fiber-2 protein, has very excellent immune performance, and effectively improves the immune effect of the recombinant virus of the traditional fowl adenovirus Fiber-2 gene; compared with the recombinant herpesvirus of turkey which singly expresses any one of the H9N2 subtype avian influenza virus H9 protein and the fowl adenovirus 4 type Fiber-2 protein, the recombinant herpesvirus of turkey has the advantage that the performance of the recombinant herpesvirus of turkey is not weakened. Meanwhile, the invention also provides application and a vaccine of the recombinant herpesvirus of turkeys.
Owner:CHINA AGRI UNIV

MRNA and mRNA-LNP vaccine thereof, preparation method and application

The invention discloses mRNA, an mRNA-LNP vaccine of the mRNA, a preparation method and application of the mRNA-LNP vaccine. The invention discloses an H5 subtype avian influenza virus vaccine, and aims to provide a vaccine which combines a mosaic sequence with an mRNA vaccine, achieves a good effect in an immune protection experiment of chickens, and can realize cross protection of branched strains of H5 subtype avian influenza virus 2.3. 4.4b and 2.3. 4.4 hours. According to the technical scheme, the nucleotide sequence of the mRNA is as shown in SEQ ID NO. 1; the nucleotide sequence of the mRNA is a Mosaic sequence which is obtained by designing a gene sequence of a 2.3. 4.4b branch strain of the avian influenza H5N6; the mRNA-LNP vaccine comprises mRNA (Messenger Ribonucleic Acid) with a nucleotide sequence as shown in SEQ ID NO. 1; belongs to the technical field of biology.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Primer probe group and kit for simultaneously detecting H5, H7 and H9 subtype and universal avian influenza viruses and application of primer probe group and kit

The invention discloses a primer probe group for simultaneously detecting H5, H7 and H9 subtype and universal avian influenza viruses. The kit comprises a probe of the H5 subtype avian influenza virus, an upstream primer of the H5 subtype avian influenza virus, a downstream primer of the H5 subtype avian influenza virus, a probe of the H7 subtype avian influenza virus, an upstream primer of the H7 subtype avian influenza virus, a downstream primer of the H7 subtype avian influenza virus, a probe of the H9 subtype avian influenza virus and an upstream primer of the H9 subtype avian influenza virus. The kit comprises an upstream primer of the H9 subtype avian influenza virus, a downstream primer of the H9 subtype avian influenza virus, a probe of the universal avian influenza virus, an upstream primer of the universal avian influenza virus and a downstream primer of the universal avian influenza virus. The invention also discloses a kit containing the primer probe group. The kit has the advantages of being simple and convenient to operate, high in sensitivity, good in specificity, capable of detecting samples anytime and anywhere, low in cross contamination rate, rapid in result obtaining and the like, suspicious samples can be found and diagnosed in time, and the rapid detection capacity of the avian influenza virus is improved.
Owner:广州中渔生物科技有限公司

Nucleic acid molecule composition, reagent and kit for detecting H9 subtype avian influenza virus based on RT-RAA / CRISPR-Cas13a / LFD and application

The invention relates to the technical field of molecular biology, in particular to a nucleic acid molecule composition for detecting H9 subtype avian influenza virus based on RT-RAA / CRISPR-Cas13a / LFD, a reagent, a kit and application. The nucleic acid molecule composition comprises an upstream primer RAA-H9-F, a downstream primer RAA-H9-R and a specific crRNA-H9, wherein the upstream primer RAA-H9-F is used for detecting the nucleic acid molecule; the sequence of the upstream primer RAA-H9-F is as shown in SEQ ID No: 1, the sequence of the downstream primer RAA-H9-R is as shown in SEQ ID No: 2, and the sequence of the specific crRNA-H9 is as shown in SEQ ID No: 3. The nucleic acid molecule composition provided by the invention can realize visual detection of the H9 subtype avian influenza virus, is high in detection accuracy, short in time consumption, good in specificity and high in sensitivity, provides a basis for rapid, simple and accurate diagnosis of the H9 subtype avian influenza virus, and meets the requirements of clinical detection.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Dual-system method for assessing transmissibility and disease severity of respiratory viruses

PendingUS20250298008A1Health-index calculationMicrobiological testing/measurementHuman airwayRespirovirus
The present invention uses ex vivo human airway cultures to assess the human transmissibility and replication competence of influenza and coronavirus strains. By comparing pandemic influenza A subtype H1N1 and highly pathogenic avian influenza H5N1 as reference strains, the transmissibility risk of various viruses was evaluated and categorized. Additionally, an in vitro model evaluated virus-induced impairment of alveolar fluid clearance (AFC) as an indicator of disease severity. The study revealed correlations between bronchus viral replication, human transmission, AFC impairment, and clinical disease severity across different influenza and coronavirus strains.
Owner:CENT FOR IMMUNOLOGY & INFECTION LTD

H9N2 subtype avian influenza virus bivalent inactivated vaccine and preparation method thereof

The invention discloses an H9N2 subtype avian influenza virus, the H9N2 subtype avian influenza virus is A / chick / Guangxi / C1228 / 2015 (H9N2), and the preservation number of the H9N2 subtype avian influenza virus is CGMCC (China General Microbiological Culture Collection Center) No.45222; or the H9N2 subtype avian influenza virus is A / quil / Guangxi / 210Q33 / 2015 (H9N2), and the preservation number is CGMCC (China General Microbiological Culture Collection Center) No. 46091. The bivalent inactivated vaccine of CK / GX / C1228 / 15 with better antigenicity and the strain QL / GX / 210Q33 / 15 which has better antigenicity and is separated from quails in the live poultry market has a better protection effect on two different branches of H9N2 subtype avian influenza viruses, the lowest immune dose (0.3 mL) can reach the protection rate of 80% or above, and the generated effective protection antibody can last to 24W.
Owner:GUANGXI VETERINARY RES INST

Probe combination, kit and detection method for detecting influenza A virus

ActiveCN118957165Aachieve specific captureRealize typing identificationMicrobiological testing/measurementMicroorganism based processesNucleic acid sequencingHypotype
The invention provides a probe combination, a kit and a detection method for detecting influenza A virus. Wherein the probe combination comprises a probe for capturing an HA gene and a probe for capturing an NA gene, and the probe combination comprises a combination of nucleic acid sequences as shown in SEQ ID NOs: 1-198. The method can solve the problem that all known subtypes of the influenza A virus are difficult to capture quickly in the prior art, and is suitable for the field of gene sequencing.
Owner:JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION (PUBLIC HEALTH RESEARCH INSTITUTE OF JIANGSU PROVINCE) +1

Recombinant nano antibody for resisting H9 subtype avian influenza virus NP protein, recombinant nano antibody protein, engineering strain and application thereof

The invention belongs to the technical field of biology, and particularly relates to a recombinant nano antibody for resisting H9 subtype avian influenza virus NP protein, a recombinant nano antibody protein, an engineering strain and application thereof. The amino acid sequence of the recombinant nano antibody for resisting the H9 subtype avian influenza virus NP protein is SEQ ID NO: 2, and the nucleotide sequence of the recombinant nano antibody is SEQ ID NO: 1. The invention also provides the application of the recombinant nano-antibody for resisting the H9 subtype avian influenza virus NP protein in preparation of a nano-antibody preparation and / or a nano-antibody kit for diagnosing the H9 subtype avian influenza virus. The recombinant nano-antibody for resisting the H9 subtype avian influenza virus NP protein, provided by the invention, is screened from an established H9 subtype avian influenza virus NP protein immune library, and an immune antigen of the recombinant nano-antibody has the sequence characteristic of a virus strain (SG strain) under a current epidemic H9.4. 2.2 branch, and has higher binding suitability with an epidemic virus strain.
Owner:NANJING PEPTIDE & BIOENGINEERING CO LTD

Anti-influenza A virus nano antibody and application thereof

The invention provides an anti-influenza A virus nano antibody and application thereof, the nano antibody comprises a heavy chain variable region, the heavy chain variable region comprises CDR1, CDR2 and CDR3, and the CDR3 of the heavy chain variable region is selected from an amino acid sequence as shown in SEQ ID NO: 8 or SEQ ID NO: 16. The anti-influenza A virus nano antibody can be combined with various influenza A viruses, including subtype influenza viruses such as H1N1, H2N2, H3N2 and H7N9, has strong broad spectrum, has different binding epitopes of the two nano antibodies, and can be applied to double antibody sandwich method detection, enzyme-linked immunosorbent assay and colloidal gold detection. According to the invention, multivalent transformation is also carried out on the nano antibody to obtain a dodecavalent hexamer cyclic structure nano antibody, so that the application scene of the anti-influenza A virus nano antibody can be further extended.
Owner:BGI TECH (CHANGZHOU) CO LTD +1

Primer composition for detecting avian influenza virus and newcastle disease virus on basis of maldi-TOF mass spectrometry detection technique and use thereof

A primer composition for detecting avian influenza virus and newcastle disease virus on the basis of MALDI-TOF mass spectrometry detection technique and the use thereof. The primer composition comprises an amplification primer set as shown in SEQ ID Nos. 1-16 and a UEP extension primer set as shown in SEQ ID Nos. 17-31. The present invention further relates to a method for detecting avian influenza virus and newcastle disease virus on the basis of MALDI-TOF mass spectrometry detection technique. The MALDI-TOF mass spectrometry detection method is sensitive and specific, and can realize the synchronous detection of multiple targets. The method is not only suitable for the rapid detection and typing of main subtypes or strain types of avian influenza virus and newcastle disease virus in the throat / cloacal swab, tissue and organs in the import and export of poultry, and can also be used for rapid screening of main subtypes or strain types of avian influenza virus and newcastle disease virus in the samples from poultry breeding enterprises.
Owner:SCIENCE & TECHNOLOGY RESEARCH CENTER OF CHINA CUSTOMS +1

Primer probe combination and kit for on-site detection of H5, H7 and H9 subtype avian influenza viruses

The invention discloses a primer probe combination and a kit for on-site detection of H5, H7 and H9 subtype avian influenza viruses, and relates to the technical field of gene detection. The invention provides a primer probe combination for detecting H5, H7 and H9 subtype avian influenza viruses on site. The primer probe combination comprises a primer pair and a probe for detecting the H5 subtype avian influenza viruses, the primer pair and the probe are used for detecting the H7 subtype avian influenza virus; the invention discloses a primer pair and a probe for detecting an H9 subtype avian influenza virus. The method for detecting the H5, H7 and H9 subtype avian influenza viruses by adopting the primer probe combination and the kit disclosed by the invention integrates sample pretreatment, nucleic acid extraction, purification, amplification and detection, has better sensitivity and accuracy, is simple, convenient, rapid and time-saving to operate, and plays an important role in on-site rapid detection of research and safety management of the H5, H7 and H9 subtype avian influenza viruses.
Owner:INTEGRATED BIOSYSTEMS CO LTD

SgRNA and application thereof, TNIP2 gene knockout cell strain and construction method of TNIP2 gene knockout cell strain

The invention relates to the technical field of biology, and discloses sgRNA for knocking out a TNIP2 gene, the nucleotide sequence is shown as SEQ ID NO: 1, blocking of the sgRNA to TNIP2 expression is verified through sanger sequencing and Western Blotting experiments, a TNIP2 knockout cell line and a control cell have no obvious morphological and growth difference, and the sgRNA can be used for knockout of the TNIP2 gene. The sgRNA can inhibit the replication ability of the H1 subtype influenza virus by regulating and controlling the expression of a host gene TNIP2, in addition, the invention further discloses application of the sgRNA, a cell strain with the TNIP2 gene knocked out and a construction method of the cell strain.
Owner:THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV (GUANGZHOU RESPIRATORY CENT) +3

Heat-resistant H1N1 subtype influenza virus mutant vaccine strain and application thereof

The invention relates to a heat-resistant H1N1 subtype influenza virus mutant vaccine strain and application thereof. The invention belongs to the technical field of virus gene engineering, and particularly discloses a heat-resistant H1N1 subtype influenza virus mutant vaccine strain and application thereof. According to the H1N1 subtype influenza virus mutant vaccine strain and the preparation method thereof, the HA protein head region, which is a key region influencing the virus thermal stability, is mutated, the virus thermal stability can be remarkably improved only by mutating three amino acid sites, meanwhile, the virus still has good thermal stability after being inactivated, the H1N1 subtype influenza virus mutant vaccine strain prepared by HA protein point mutation has the preservation number of CCTCC NO: V202471, and the H1N1 subtype influenza virus mutant vaccine strain can be used for preparing the H1N1 subtype influenza virus mutant vaccine strain. And immune animals can be induced to generate high-level HI antibodies.
Owner:INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI +1

2.3. 4.4b branch H5 subtype avian influenza virus strain and application thereof

The invention discloses a 2.3. 4.4b branch H5 subtype avian influenza virus strain and an application thereof. The 2.3. 4.4b branch H5 subtype avian influenza virus strain is an A type avian influenza virus A / chick / Shenyang / 12301 / 2024, is preserved in the China General Microbiological Culture Collection Center (CGMCC), has a preservation number of CGMCC No.46299, and is preserved for December 12, 2024, and the strain has a preservation number of CGMCC No.46299, a preservation number of CGMCC No.46299, a preservation number of CGMCC No.46299 and a preservation number of CGMCC No.46299. According to the invention, 2.3. 4.4b branch H5 subtype AIV with good cross immunoreaction is searched as a vaccine candidate strain to form a whole virus inactivated vaccine, so as to effectively prevent and control the infection of the latest epidemic H5 subtype AIV to poultry, and further eliminate the potential threat of influenza virus to public health safety in poultry breeding.
Owner:CHINA AGRI UNIV SANYA RES INST

Quadruple fluorescent quantitative PCR (Polymerase Chain Reaction) primer probe group for rapidly detecting four pathogens of birds and application of quadruple fluorescent quantitative PCR primer probe group

The invention discloses a quadruple fluorescent quantitative PCR (Polymerase Chain Reaction) primer probe group for rapidly detecting four pathogens of birds and application, and belongs to the technical field of biology. The kit comprises specific primers and probes aiming at coronavirus (gamma, delta), avian influenza virus (H9 subtype), Newcastle disease virus and West Nile virus; the reagent disclosed by the invention is used for detecting four viruses carried by birds, and has the advantages of high specificity, strong sensitivity, short detection time, safety, low cost and the like; the method can realize detection of pathogens carried by birds, and is of great significance to customs frontier defense and quarantine work.
Owner:KUNMING UNIV OF SCI & TECH

Veterinary vaccine composite adjuvant as well as preparation method and application thereof

The invention discloses a veterinary vaccine composite adjuvant as well as a preparation method and application thereof. Active ingredients in the vaccine composite adjuvant are a manganese-containing compound and a Mincle agonist. According to the veterinary vaccine composite adjuvant disclosed by the invention, Mn and TDB are combined, so that the immunological enhancement effect of the TDB adjuvant is achieved. The composite adjuvant can induce a strong immune response reaction, significantly improves the immune effect, and is free of residual damage in use. Compared with the H7N9 vaccine prepared by singly using DDA-TDB, the H7N9 vaccine prepared by mixing the H7N9 subtype avian influenza inactivated virus as the antigen with the composite adjuvant can enhance humoral immunity and cellular immune response of a body, reduce virus load and improve protection level, and provides a product and technical support for production of veterinary vaccines.
Owner:YANGZHOU UNIV

Kit for rapidly detecting avian leukosis J subtype based on CRISPR / Cas13a system

The invention discloses a kit for rapidly detecting avian leukosis J subtype based on a CRISPR / Cas13a (clustered regularly interspaced short palindromic repeats / associated protein 13a) system, the method is a method for detecting ALV-J (avian leukosis virus-J) based on the CRISPR / Cas13a system and RAA amplification combination, an oligonucleotide probe is designed as a substrate for CRISPR / Cas13a trans-cleavage, and a detectable signal is generated. According to the method, a detection signal is amplified twice through RAA amplification and T7 transcription, so that the detection sensitivity can be greatly improved. The detection method also has good specificity, can clearly distinguish other poultry viruses, does not need expensive experimental equipment and special laboratory environment, and is rapid and efficient. The method is of great significance to biological research and on-site detection of ALV-J.
Owner:SOUTHWEST UNIV

Real-time fluorescence PCR detection kit and detection method for H10N7 avian influenza virus

This application relates to the field of virus detection technology, specifically disclosing a real-time fluorescent PCR detection kit and method for H10N7 avian influenza virus. The kit includes sample lysis extract, sample washing solution I, sample washing solution II, and reaction premix for detecting H10N7 subtype avian influenza virus; the detection method is an integrated detection method. This application achieves simultaneous detection of H10 and N7 subtype AIVs by designing specific primers and probes. The kit prepared using these primers and probes not only improves detection efficiency but also significantly enhances sensitivity and specificity. The combined use of MAOPA technology and real-time quantitative PCR technology further improves the accuracy of the detection results, making this kit of this application of significant application value in avian influenza prevention and control.
Owner:TAIZHOU LEILING BIOTECH CO LTD

Nucleic acid molecule composition, reagent and kit for detecting H7 subtype avian influenza virus based on RT-RAA / CRISPR-Cas13a / LFD and application

The invention relates to the technical field of molecular biology, in particular to a nucleic acid molecule composition for detecting H7 subtype avian influenza virus based on RT-RAA / CRISPR-Cas13a / LFD, a reagent, a kit and application. The nucleic acid molecule composition comprises an upstream primer RAA-H7-F, a downstream primer RAA-H7-R and a specific crRNA-H7, wherein the upstream primer RAA-H7-F and the downstream primer RAA-H7-R are used as primers of the nucleic acid molecule The sequence of the upstream primer RAA-H7-F is as shown in SEQ ID No: 1, the sequence of the downstream primer RAA-H7-R is as shown in SEQ ID No: 2, and the sequence of the specific crRNA-H7 is as shown in SEQ ID No: 3. The nucleic acid molecule composition provided by the invention can realize visual detection of the H7 subtype avian influenza virus, is high in detection accuracy, short in time consumption, good in specificity and high in sensitivity, provides a basis for rapid, simple and accurate diagnosis of the H7 subtype avian influenza virus, and meets the requirements of clinical detection.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Monoclonal antibody 1H1 for resisting H6 subtype avian influenza virus hemagglutinin protein and application of monoclonal antibody 1H1

The invention belongs to the technical field of biology, and relates to an anti-H6 subtype avian influenza virus hemagglutinin protein monoclonal antibody 1H1 and application thereof, cell engineering and antibody engineering technologies are utilized to obtain a hybridoma cell line for secreting a hemagglutinin monoclonal antibody, ascites is induced by mice of the same strain to prepare the anti-hemagglutinin protein monoclonal antibody 1H1, the anti-hemagglutinin protein monoclonal antibody 1H1 is identified as an IgG1, kappa type, and the anti-hemagglutinin protein monoclonal antibody 1H1 is identified as an anti-H6 subtype avian influenza virus hemagglutinin protein monoclonal antibody. And the application of the antibody is realized through technologies of affinity purification, immunization and the like. The monoclonal antibody has the advantages that the preparation method is simple and easy to implement, more importantly, the monoclonal antibody prepared by the method can have multiple purposes, an effective tool is provided for auxiliary diagnosis of H6 subtype avian influenza virus infection in a clinical sample, and the monoclonal antibody can be popularized and applied to multiple detection technologies and clinical and experimental research.
Owner:THE FIRST AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE